GlassScriptPhysician profile
Frank S Powell
NPI 1760466874
$8,467.88
in general payments reported to CMS, 2019-2025
45 companies · $1,216 in 2025
The $1,216 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,808 · 2020: $252 · 2021: $513 · 2022: $561 · 2023: $730 · 2024: $388 · 2025: $1,216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,793 · Travel and Lodging: $541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,793.05 |
| Travel and Lodging | $541.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,555.76 | 2019-2025 | Da Vinci Surgical System |
| Medtronic Vascular, INC. | $1,374.34 | 2019 | |
| Elucent Medical | $316.30 | 2022-2024 | |
| Davol INC. | $282.95 | 2019-2025 | Phasix Mesh, Arista |
| Allergan, INC. | $178.67 | 2020-2022 | |
| Tela Bio, INC. | $156.48 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Kowa Pharmaceuticals America, INC. | $154.93 | 2022-2023 | Seglentis |
| Innocoll Pharmaceuticals Limited | $131.60 | 2021-2022 | |
| Stryker Corporation | $126.39 | 2020-2021 | |
| Integra Lifesciences Corporation | $114.48 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Baxter Healthcare | $98.99 | 2020-2024 | Perclot |
| Medtronic, INC. | $69.08 | 2021-2024 | Pteye Parathyroid Detection System |
| Pacira Pharmaceuticals Incorporated | $59.54 | 2021-2024 | Iovera, Exparel, Zilretta |
| Kci USA, INC. | $58.08 | 2020-2023 | Prevena, V.A.C.Ulta, V.A.C. Veraflo |
| Braintree Laboratories, INC. | $50.42 | 2023-2025 | Suflave, Sutab |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $47.19 | 2022 | |
| Conmed Corporation | $44.07 | 2024-2025 | Airseal, Visiclear |
| Myriad Genetic Laboratories, INC. | $39.67 | 2021 | |
| Abbvie INC. | $38.64 | 2023 | |
| Hologic Sales and Service, LLC | $37.87 | 2023-2024 | Trunode, Localizer |
| Abbott Laboratories | $37.29 | 2020-2025 | Eterna |
| Heron Therapeutics, INC. | $35.12 | 2021-2022 | |
| Biom'Up France Sas | $34.78 | 2020 | |
| Bioventus LLC | $30.50 | 2023 | Sonicone Clinic |
| Becton, Dickinson and Company | $29.34 | 2023 | Phasix Mesh |
| Merck Sharp & Dohme LLC | $27.66 | 2025 | Lynparza, Keytruda |
| Solventum Corporation | $26.85 | 2024 | V.A.C. Veraflo, V.A.C.Ulta, Prevena |
| Teleflex LLC | $25.79 | 2019-2021 | |
| Ets Wound Care LLC | $25.21 | 2025 | Mirragen Advanced Wound Matrix |
| Lifenet Health | $23.36 | 2023 | |
| Phathom Pharmaceuticals, INC. | $21.90 | 2024 | Voquezna |
| Polynovo North America LLC | $21.79 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $20.95 | 2023 | Libtayo |
| Ethicon US, LLC | $20.55 | 2019 | |
| Impedimed, INC. | $19.49 | 2024 | |
| Amgen INC. | $18.14 | 2019 | |
| Endo Pharmaceuticals INC. | $14.06 | 2021 | |
| Reprise Biomedical, INC. | $13.23 | 2021 | |
| Tei Biosciences INC | $13.01 | 2019 | |
| Vanda Pharmaceuticals INC. | $12.93 | 2021 | |
| Nalpropion Pharmaceuticals LLC | $12.79 | 2019 | |
| Molnlycke Health Care US, LLC | $12.31 | 2024 | Avance, Mepilex Border Post-Op Ag |
| Tactile Systems Technology INC | $12.14 | 2022 | |
| Focal Therapeutics, INC. | $11.70 | 2019 | |
| Ambu INC. | $11.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Powell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.